Redefining Human Vitamin D Sufficiency: Back to the Basics

Abstract

The role of the endocrine vitamin D pathway in regulating the serum calcium concentration in man is well described. In the presence of a low serum calcium level, the vitamin D metabolic pathway is called upon to produce more of the active vitamin D hormone, 1, 25-dihydroxyvitamin D (1, 25-D), via up-regulation of the CYP27b1-hydroxylase activity in the kidney. The consequence is mobilization of skeletal calcium stores to return the circulating calcium level back to the normal range. On the other hand, when the serum calcium level increases, endocrine forces move to suppress renal 1, 25D production and squelch bone resorption. It is now known that vitamin D metabolites also operate in an autocrine, paracrine and intracrine mode to control vitamin D receptor-directed biological responses at the tissue level. Because the metabolism and action of vitamin D occurs at the tissue level in this situation, use of circulating vitamin D metabolites and biomarkers to ascertain the local action of the vitamin D pathway is often misleading. This mini-review seeks to compare and contrast the operation of the vitamin D pathway at the endocrine and tissue level.

References

[1] Zhu J, DeLuca HF. Vitamin D 25-hydroxylase—Four decades of searching, are we there yet? Arch Biochem Biophys, 2012, 523: 30-36

[2] Endres DB. Investigation of hypercalcemia. Clin Biochem, 2012, 45: 954-963

[3] Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res, 2012, 318: 1040-1048

[4] Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys, 2012, 523: 95-102

[5] Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 2006, 311: 1770-1773

[6] Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys, 2012, 523: 9-18

[7] Holick MF. Vitamin D deficiency. N Engl J Med, 2007, 357: 266-281

[8] Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int, 1997, 7: 439-443

[9] Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab, 2010, 95: 471-478

[10] Brown EM. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Subcell Biochem, 2007, 45: 139-167

[11] Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol, 2011, 22: 216-224

[12] Bajwa A, Forster MN, Maiti A, Woolbright BL, Beckman MJ. Specific regulation of CYP27B1 and VDR in proximal versus distal renal cells. Arch Biochem Biophys, 2008, 477: 33-42

[13] Wysolmerski JJ. Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab, 2012, 97: 2947-2956

[14] Takyar FM, Tonna S, Ho PW, Crimeen-Irwin B, Baker EK, Martin TJ, Sims NA . EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. J Bone Miner Res. 2012 [Epub ahead of print].

[15] Qing H, Ardeshirpour L, Pajevic PD, Dusevich V, Jahn K, Kato S, Wysolmerski J, Bonewald LF. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res, 2012, 27: 1018-1029

[16] Suda T, Takahashi F, Takahashi N. Bone effects of vitamin D — Discrepancies between in vivo and in vitro studies. Arch Biochem Biophys, 2012, 523: 22-29

[17] Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab, 2009, 20: 230-236

[18] Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, Faugere MC, Aja S, Hussain MA, Bruning JC, Clemens TL. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell, 2010, 142: 309-319

[19] Wesseling-Perry K, Juppner H . The osteocyte in CKD: New concepts regarding the role of FGF23 in mineral metabolism and systemic complications. Bone. 2012 [Epub ahead of print].

[20] Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP. Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest, 2011, 34: 801-810

[21] Kumar R, Tebben PJ, Thompson JR. Vitamin D and the kidney. Arch Biochem Biophys, 2012, 523: 77-86

[22] Fleet JC, Schoch RD, Feldman D. Molecular Mechanisms for regulation of intestinal calcium and phosphate absorption by vitamin D. Vitamin D, 2011 London Elsevier

[23] Christakos S. Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption. Arch Biochem Biophys, 2012, 523: 73-76

[24] Nordin BE. Evolution of the calcium paradigm: the relation between vitamin D, serum calcium and calcium absorption. Nutrients, 2010, 2: 997-1004

[25] Andreassen TK. The role of plasma-binding proteins in the cellular uptake of lipophilic vitamins and steroids. Horm Metab Res, 2006, 38: 279-290

[26] Chun RF. New perspectives on the vitamin D binding protein. Cell Biochem Funct, 2012, 30: 445-456

[27] Bienaime F, Prie D, Friedlander G, Souberbielle JC. Vitamin D metabolism and activity in the parathyroid gland. Mol Cell Endocrinol, 2011, 347: 30-41

[28] Salusky IB. Are new vitamin D analogues in renal bone disease superior to calcitriol? Pediatr Nephrol, 2005, 20: 393-398

[29] Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96: 1911-1930

[30] Anderson PH, Turner AG, Morris HA. Vitamin D actions to regulate calcium and skeletal homeostasis. Clin Biochem, 2012, 45: 880-886

[31] Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res, 1987, 2: 595-610

[32] Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Püschel K, Amling M. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res, 2010, 25: 305-312

[33] Rosen CJ, Gallagher JC. The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom, 2011, 14: 79-84

[34] Ott SM. Bone histomorphometry in renal osteodystrophy. Semin Nephrol, 2009, 29: 122-132

[35] Anderson PH, Atkins GJ, Turner AG, Kogawa M, Findlay DM, Morris HA. Vitamin D metabolism within bone cells: effects on bone structure and strength. Mol Cell Endocrinol, 2011, 347: 42-47

[36] Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ. 25-Hydroxy-vitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int, 2006, 70: 654-659

[37] Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol Med, 2007, 13: 117-124

[38] Liu PT, Modlin RL. Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol, 2008, 20: 371-376

[39] Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL, Hewison M. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol, 2009, 182: 4289-4295

[40] Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, Lee HM, Krutzik SR, Schenk M, Sieling PA, Teles R, Montoya D, Iyer SS, Bruns H, Lewinsohn DM, Hollis BW, Hewison M, Adams JS, Steinmeyer A, Zügel U, Cheng G, Jo EK, Bloom BR, Modlin RL. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med, 2011, 3: 104ra102

[41] Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev, 2012, 33 3 456-492

[42] Adams JS, Gacad MA. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med, 1985, 161: 755-765

[43] Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M, Keegan C, Krutzik SR, Adams JS, Hewison M, Modlin RL. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A, 2010, 107: 22593-22598

[44] Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab, 2008, 4: 80-90

[45] Adams JS. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am, 1989, 18: 765-778

[46] Singer FR, Adams JS. Abnormal calcium homeostasis in sarcoidosis. N Engl J Med, 1986, 315: 755

[47] Wu S, Ren S, Nguyen L, Adams JS, Hewison M. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology, 2007, 148 7 3410-3418

[48] Ito N, Findlay DM, Anderson PH, Bonewald LF, Atkins GJ . Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D(3) (1,25D) on osteocyte like cells. J Steroid Biochem Mol Biol. 2012 [Epub ahead of print].